市場調查報告書

全球經前症候群治療藥市場:各類型藥,各分類,各流通管道的機會分析與產業預測,2019年∼2026年

Premenstrual Syndrome Treatment Market by Drug Type, Type, and Distribution Channel : Global Opportunity Analysis and Industry Forecast, 2019-2026

出版商 Allied Market Research 商品編碼 927304
出版日期 內容資訊 英文 241 Pages
商品交期: 2-3個工作天內
價格
全球經前症候群治療藥市場:各類型藥,各分類,各流通管道的機會分析與產業預測,2019年∼2026年 Premenstrual Syndrome Treatment Market by Drug Type, Type, and Distribution Channel : Global Opportunity Analysis and Industry Forecast, 2019-2026
出版日期: 2020年01月01日內容資訊: 英文 241 Pages
簡介

經前綜合症(PMS)是指女性月經開始前一到兩週出現的身體和情緒症狀,例如粉刺,乳房壓痛,情緒波動,腹脹,不適和煩躁不安等特徵性症狀。改變生活方式有望緩解PMS症狀,但應根據症狀的嚴重程度使用不同類型的藥物,例如止痛藥,抗抑鬱藥和利尿藥。由於諸如提高患者意識,增長的目標人群,需求增長以及更容易獲得藥物等因素,PMS藥物市場預計將顯著增長。全球市場規模預測將從2018年的11億2,900萬美元達到2026年15億1,600萬美元,2019年∼2026年間年複合成長率將為3.7%。

本報告提供全球PMS治療藥市場調查,提供促進市場成長的要素及阻礙因素,各類型藥,各分類,各流通管道,各地區的分析,主要企業的簡介等資訊。

目錄

第1章 簡介

  • 報告概要
  • 利害關係者的主要優點
  • 主要市場區隔
    • 主要企業的清單
  • 調查手法
    • 二次調查
    • 一次調查
    • 分析師的工具和模式

第2章 摘要整理

  • 主要調查結果
  • 主要調查結果
    • 主要的投資資金
    • 主要企業的立場,2018年
  • Cxo的見解

第3章 市場概要

  • 市場定義和範圍
  • 產業與市場形成的主要力
    • 供給企業的力量
    • 新加入企業的威脅
    • 替代產品的威脅
    • 競爭狀況
    • 購買方面企業談判力
  • 市場動態
    • 成長促進因素
    • 成長阻礙因素
    • 市場機會
    • 影響分析

第4章 市場分析:各類型藥

  • 概要
    • 市場規模與預測
  • 止痛藥
    • 主要市場趨勢與機會
    • 市場規模與預測:各地區
    • 市場分析:各國
  • 抗憂鬱症藥
  • 口服避孕藥及卵巢抑制劑
  • 其他

第5章 市場分析:各分類。

  • 概要
    • 市場規模與預測
  • 處方藥
  • 成藥

第6章 市場分析:各流通管道

  • 概要
    • 市場規模與預測
  • 醫院內的藥局
  • 藥妝店與零售藥局
  • 線上藥局

第7章 市場分析:各地區

  • 概要
    • 市場規模與預測
  • 北美
    • 主要市場趨勢,成長要素,機會
    • 市場規模與預測:各國
    • 市場規模與預測:各類型藥
    • 市場分析:各分類
    • 市場分析:各流通管道
  • 歐洲
  • 亞太地區
  • 南美·中東·非洲

第8章 企業簡介

  • Abbvie Inc.
  • Astrazeneca Plc
  • Basf Corporation
  • Bayer Ag.
  • Dr. Reddy'S Laboratories Ltd
  • Eli Lilly And Company.
  • Glaxosmithkline Plc.
  • H. Lundbeck A/S
  • Pfizer Inc.
  • Shionogi Inc.
目錄
Product Code: LI_206330

The global premenstrual syndrome treatment market was valued at $1,129 million in 2018, and is projected to reach $1,516 million by 2026, registering a CAGR of 3.7% from 2019 to 2026.

Premenstrual syndrome or PMS refers to physical & emotional symptoms, which occur one to two weeks before the initiation of woman's menses. It is characterized by symptoms such as acne, tender breasts, mood swings, bloating, fatigue, and irritability. Lifestyle changes are anticipated to help relieve PMS symptoms. However, based on the severity of symptoms, different types of drugs such as analgesics, antidepressants, and diuretics are used.

The premenstrual syndrome treatment market is expected to experience a significant growth during the forecast period, owing to increase in awareness among patients, higher number of target population, rise in demand for PMS drugs, and easy availability of drugs. In addition, campaigns from government and non-government organizations to elevate female health status and education supports the market growth. However, unknown etiology and pathophysiology of PMS is anticipated to hamper the market growth.

The global premenstrual syndrome treatment market is segmented on the basis of drug type, distribution channel, and region. By drug type, it is classified into analgesics, antidepressants, oral contraceptives & ovarian suppression agents, and others. Based on type market is classified as prescription and OTC. According to distribution channel, the market is categorized as hospital pharmacies, drug stores & retail pharmacies, and online providers. Region wise, the market is studied across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).

KEY BENEFITS FOR STAKEHOLDERS

  • The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate imminent investment pockets.
  • It offers a quantitative analysis from 2018 to 2026, which is expected to enable stakeholders to capitalize on the prevailing market opportunities.
  • A comprehensive analysis of major four geographical regions is provided to determine the existing opportunities.
  • The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global market.

KEY MARKET SEGMENTS

By Drug Type

  • Analgesics
  • Antidepressants
  • Oral Contraceptives & Ovarian Suppression Agents
  • Others
  • Type
  • Prescription
  • OTC

By Distribution Channel

  • Hospital Pharmacies
  • Drug Stores & Retail Pharmacies
  • Online Providers

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • Australia
  • India
  • South Korea
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA
  • LIST OF KEY PLAYERS PROFILED IN THE REPORT
  • ABBVIE INC.
  • AstraZeneca plc.
  • BASF Corporation
  • Bayer AG
  • Dr. Reddy's Laboratories Ltd
  • Eli Lilly And Company
  • GlaxoSmithKline Plc
  • H. Lundbeck A/S
  • Pfizer Inc
  • Shionogi Inc
  • LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request.)
  • Teva Pharmaceutical Industries Ltd.
  • Allergan PLC

Table of Contents

Chapter 1: Introduction

  • 1.1. Report Description
  • 1.2. Key Benefits For Stakeholders
  • 1.3. Key Market Segments
    • 1.3.1. List of Key Players Profiled In The Report
  • 1.4. Research Methodology
    • 1.4.1. Secondary Research
    • 1.4.2. Primary Research
    • 1.4.3. Analyst Tools And Models

Chapter 2: Executive Summary

  • 2.1. Key Findings of The Study
  • 2.2. Key Findings
    • 2.2.1. Top Investment Pockets
    • 2.2.2. Top Player Positioning, 2018
  • 2.3. Cxo Perspective

Chapter 3: Market Overview

  • 3.1. Market Definition And Scope
  • 3.2. Key Forces Shaping Premenstrual Syndrome Treatment Industry/Market
    • 3.2.1. Moderate Power of Suppliers
    • 3.2.2. Moderate Threat of New Entrants
    • 3.2.3. Low Threat of Substitution
    • 3.2.4. Moderate Competitive Rivalry
    • 3.2.5. Moderate Bargaining Power of Buyers
  • 3.3. Market Dynamics
    • 3.3.1. Drivers
      • 3.3.1.1. Increase In Prevalence of Pms
      • 3.3.1.2. Growth In Awareness For Pms Therapeutics
      • 3.3.1.3. Surge In Healthcare Expenditure Worldwide
    • 3.3.2. Restraint
      • 3.3.2.1. Poor Demand In Under Developed Countries
    • 3.3.3. Opportunities
      • 3.3.3.1. Growth Opportunities In Emerging Markets
      • 3.3.3.2. Higher Number of Unmet Needs For Treatment of Pms
    • 3.3.4. Impact Analysis

Chapter 4: Premenstrual Syndrome Treatment Market, By Drug Type

  • 4.1. Overview
    • 4.1.1. Market Size And Forecast
  • 4.2. Analgesics
    • 4.2.1. Key Market Trends And Opportunities
    • 4.2.2. Market Size And Forecast, By Region
    • 4.2.3. Market Analysis, By Country
  • 4.3. Antidepressants
    • 4.3.1. Key Market Trends And Opportunities
    • 4.3.2. Market Size And Forecast, By Region
    • 4.3.3. Market Analysis, By Country
  • 4.4. Oral Contraceptives & Ovarian Suppression Agents
    • 4.4.1. Key Market Trends And Opportunities
    • 4.4.2. Market Size And Forecast, By Region
    • 4.4.3. Market Analysis, By Country
  • 4.5. Others
    • 4.5.1. Key Market Trends And Opportunities
    • 4.5.2. Market Size And Forecast, By Region
    • 4.5.3. Market Analysis, By Country

Chapter 5: Premenstrual Syndrome Treatment Market, By Type.

  • 5.1. Overview
    • 5.1.1. Market Size And Forecast
  • 5.2. Prescription
    • 5.2.1. Market Size And Forecast, By Region
    • 5.2.2. Market Analysis, By Country
  • 5.3. Otc
    • 5.3.1. Market Size And Forecast, By Region
    • 5.3.2. Market Analysis, By Country

Chapter 6: Premenstrual Syndrome Treatment Market, By Distribution Channel

  • 6.1. Overview
    • 6.1.1. Market Size And Forecast
  • 6.2. Hospitals Pharmacies
    • 6.2.1. Market Size And Forecast
    • 6.2.2. Market Analysis, By Country
  • 6.3. Drug Stores & Retail Pharmacies
    • 6.3.1. Market Size And Forecast
    • 6.3.2. Market Analysis, By Country
  • 6.4. Online Pharmacies
    • 6.4.1. Market Size And Forecast
    • 6.4.2. Market Analysis, By Country

Chapter 7: Premenstrual Syndrome Treatment Market, By Region

  • 7.1. Overview
    • 7.1.1. Market Size And Forecast
  • 7.2. North America
    • 7.2.1. Key Market Trends, Growth Factors, And Opportunities
    • 7.2.2. Market Size And Forecast, By Country
      • 7.2.2.1. U.S.
      • 7.2.2.1.1. U.S. Premenstrual Syndrome Treatment Market, By Drug Type
      • 7.2.2.1.2. U.S. Premenstrual Syndrome Treatment Market, By Type
      • 7.2.2.1.3. U.S. Premenstrual Syndrome Treatment Market, By Distribution Channel
      • 7.2.2.2. Canada
      • 7.2.2.2.1. Canada Premenstrual Syndrome Treatment Market, By Drug Type
      • 7.2.2.2.2. Canada Premenstrual Syndrome Treatment Market, By Type
      • 7.2.2.2.3. Canada Premenstrual Syndrome Treatment Market, By Distribution Channel
      • 7.2.2.3. Mexico
      • 7.2.2.3.1. Mexico Premenstrual Syndrome Treatment Market, By Drug Type
      • 7.2.2.3.2. Mexico Premenstrual Syndrome Treatment Market, By Type
      • 7.2.2.3.3. Mexico Premenstrual Syndrome Treatment Market, By Distribution Channel
    • 7.2.3. North America Market Size And Forecast, By Drug Type
    • 7.2.4. North America Premenstrual Syndrome Treatment Market, By Type
    • 7.2.5. North America Premenstrual Syndrome Treatment Market, By Distribution Channel
  • 7.3. Europe
    • 7.3.1. Key Market Trends, Growth Factors, And Opportunities
    • 7.3.2. Market Size And Forecast, By Country
      • 7.3.2.1. Germany
      • 7.3.2.1.1. Germany Premenstrual Syndrome Treatment Market, By Drug Type
      • 7.3.2.1.2. Germany Premenstrual Syndrome Treatment Market, By Type
      • 7.3.2.1.3. Germany Premenstrual Syndrome Treatment Market, By Distribution Channel
      • 7.3.2.2. France
      • 7.3.2.2.1. France Premenstrual Syndrome Treatment Market, By Drug Type
      • 7.3.2.2.2. France Premenstrual Syndrome Treatment Market, By Type
      • 7.3.2.2.3. France Premenstrual Syndrome Treatment Market, By Distribution Channel
      • 7.3.2.3. Uk
      • 7.3.2.3.1. Uk Premenstrual Syndrome Treatment Market, By Drug Type
      • 7.3.2.3.2. Uk Premenstrual Syndrome Treatment Market, By Type
      • 7.3.2.3.3. Uk Premenstrual Syndrome Treatment Market, By Distribution Channel
      • 7.3.2.4. Italy
      • 7.3.2.4.1. Italy Premenstrual Syndrome Treatment Market, By Drug Type
      • 7.3.2.4.2. Italy Premenstrual Syndrome Treatment Market, By Type
      • 7.3.2.4.3. Italy Premenstrual Syndrome Treatment Market, By Distribution Channel
      • 7.3.2.5. Spain
      • 7.3.2.5.1. Spain Premenstrual Syndrome Treatment Market, By Drug Type
      • 7.3.2.5.2. Spain Premenstrual Syndrome Treatment Market, By Type
      • 7.3.2.5.3. Spain Premenstrual Syndrome Treatment Market, By Distribution Channel
      • 7.3.2.6. Rest of Europe
      • 7.3.2.6.1. Rest of Europe Premenstrual Syndrome Treatment Market, By Drug Type
      • 7.3.2.6.2. Rest of Europe Premenstrual Syndrome Treatment Market, By Type
      • 7.3.2.6.3. Rest of Europe Premenstrual Syndrome Treatment Market, By Distribution Channel
    • 7.3.3. Europe Market Size And Forecast, By Drug Type
    • 7.3.4. Europe Premenstrual Syndrome Treatment Market, By Type
    • 7.3.5. Europe Premenstrual Syndrome Treatment Market, By Distribution Channel
  • 7.4. Asia-Pacific
    • 7.4.1. Key Market Trends, Growth Factors, And Opportunities
    • 7.4.2. Market Size And Forecast, By Country
      • 7.4.2.1. Japan
      • 7.4.2.1.1. Japan Premenstrual Syndrome Treatment Market, By Drug Type
      • 7.4.2.1.2. Japan Premenstrual Syndrome Treatment Market, By Type
      • 7.4.2.1.3. Japan Premenstrual Syndrome Treatment Market, By Distribution Channel
      • 7.4.2.2. China
      • 7.4.2.2.1. China Premenstrual Syndrome Treatment Market, By Drug Type
      • 7.4.2.2.2. China Premenstrual Syndrome Treatment Market, By Type
      • 7.4.2.2.3. China Premenstrual Syndrome Treatment Market, By Distribution Channel
      • 7.4.2.3. Australia
      • 7.4.2.3.1. Australia Premenstrual Syndrome Treatment Market, By Drug Type
      • 7.4.2.3.2. Australia Premenstrual Syndrome Treatment Market, By Type
      • 7.4.2.3.3. Australia Premenstrual Syndrome Treatment Market, By Distribution Channel
      • 7.4.2.4. India
      • 7.4.2.4.1. India Premenstrual Syndrome Treatment Market, By Drug Type
      • 7.4.2.4.2. India Premenstrual Syndrome Treatment Market, By Type
      • 7.4.2.4.3. India Premenstrual Syndrome Treatment Market, By Distribution Channel
      • 7.4.2.5. South Korea
      • 7.4.2.5.1. South Korea Premenstrual Syndrome Treatment Market, By Drug Type
      • 7.4.2.5.2. South Korea Premenstrual Syndrome Treatment Market, By Type
      • 7.4.2.5.3. South Korea Premenstrual Syndrome Treatment Market, By Distribution Channel
      • 7.4.2.6. Rest of Asia-Pacific
      • 7.4.2.6.1. Rest of Asia-Pacific Premenstrual Syndrome Treatment Market, By Drug Type
      • 7.4.2.6.2. Rest of Asia-Pacific Premenstrual Syndrome Treatment Market, By Type
      • 7.4.2.6.3. Rest of Asia-Pacific Premenstrual Syndrome Treatment Market, By Distribution Channel
    • 7.4.3. Asia-Pacific Market Size And Forecast, By Drug Type
    • 7.4.4. Asia-Pacific Premenstrual Syndrome Treatment Market, By Type
    • 7.4.5. Asia-Pacific Premenstrual Syndrome Treatment Market, By Distribution Channel
  • 7.5. Lamea
    • 7.5.1. Key Market Trends, Growth Factors, And Opportunities
    • 7.5.2. Market Size And Forecast, By Country
      • 7.5.2.1. Brazil
      • 7.5.2.1.1. Brazil Premenstrual Syndrome Treatment Market, By Drug Type
      • 7.5.2.1.2. Brazil Premenstrual Syndrome Treatment Market, By Type
      • 7.5.2.1.3. Brazil Premenstrual Syndrome Treatment Market, By Distribution Channel
      • 7.5.2.2. Saudi Arabia
      • 7.5.2.2.1. Saudi Arabia Premenstrual Syndrome Treatment Market, By Drug Type
      • 7.5.2.2.2. Saudi Arabia Premenstrual Syndrome Treatment Market, By Type
      • 7.5.2.2.3. Saudi Arabia Premenstrual Syndrome Treatment Market, By Distribution Channel
      • 7.5.2.3. South Africa
      • 7.5.2.3.1. South Africa Premenstrual Syndrome Treatment Market, By Drug Type
      • 7.5.2.3.2. South Africa Premenstrual Syndrome Treatment Market, By Type
      • 7.5.2.3.3. South Africa Premenstrual Syndrome Treatment Market, By Distribution Channel
      • 7.5.2.4. Rest of Lamea
      • 7.5.2.4.1. Rest of Lamea Premenstrual Syndrome Treatment Market, By Drug Type
      • 7.5.2.4.2. Rest of Lamea Premenstrual Syndrome Treatment Market, By Type
      • 7.5.2.4.3. Rest of Lamea Premenstrual Syndrome Treatment Market, By Distribution Channel
    • 7.5.3. Lamea Market Size And Forecast, By Drug Type
    • 7.5.4. Lamea Premenstrual Syndrome Treatment Market, By Type
    • 7.5.5. Lamea Premenstrual Syndrome Treatment Market, By Distribution Channel

Chapter 8: Company Profiles

  • 8.1. Abbvie Inc.
    • 8.1.1. Company Overview
    • 8.1.2. Company Snapshot
    • 8.1.3. Operating Business Segments
    • 8.1.4. Product Portfolio
    • 8.1.5. Business Performance
  • 8.2. Astrazeneca Plc
    • 8.2.1. Company Overview
    • 8.2.2. Company Snapshot
    • 8.2.3. Operating Business Segments
    • 8.2.4. Product Portfolio
    • 8.2.5. Business Performance
    • 8.2.6. Key Strategic Moves And Developments
  • 8.3. Basf Corporation
    • 8.3.1. Company Overview
    • 8.3.2. Company Snapshot
    • 8.3.3. Operating Business Segments
    • 8.3.4. Product Portfolio
    • 8.3.5. Business Performance
  • 8.4. Bayer Ag.
    • 8.4.1. Company Overview
    • 8.4.2. Operating Business Segments
    • 8.4.3. Product Portfolio
    • 8.4.4. Business Performance
  • 8.5. Dr. Reddy'S Laboratories Ltd
    • 8.5.1. Company Overview
    • 8.5.2. Company Snapshot
    • 8.5.3. Operating Business Segments
    • 8.5.4. Product Portfolio
    • 8.5.5. Business Performance
  • 8.6. Eli Lilly And Company.
    • 8.6.1. Company Overview
    • 8.6.2. Company Snapshot
    • 8.6.3. Operating Business Segments
    • 8.6.4. Product Portfolio
    • 8.6.5. Business Performance
  • 8.7. Glaxosmithkline Plc.
    • 8.7.1. Company Overview
    • 8.7.2. Company Snapshot
    • 8.7.3. Operating Business Segments
    • 8.7.4. Product Portfolio
    • 8.7.5. Business Performance
  • 8.8. H. Lundbeck A/S
    • 8.8.1. Company Overview
    • 8.8.2. Company Snapshot
    • 8.8.3. Operating Business Segments
    • 8.8.4. Product Portfolio
    • 8.8.5. Business Performance
  • 8.9. Pfizer Inc.
    • 8.9.1. Company Overview
    • 8.9.2. Company Snapshot
    • 8.9.3. Operating Business Segments
    • 8.9.4. Product Portfolio
    • 8.9.5. Business Performance
  • 8.10. Shionogi Inc.
    • 8.10.1. Company Overview
    • 8.10.2. Operating Business Segments
    • 8.10.3. Product Portfolio
    • 8.10.4. Business Performance

List of Tables

  • Table 01. Global Premenstrual Syndrome Treatment Market, By Drug Type, 2018-2026 ($Million)
  • Table 02. Analgesics Market, By Region, 2018-2026 ($Million)
  • Table 03. Antidepressants Market, By Region, 2018-2026 ($Million)
  • Table 04. Oral Contraceptives & Ovarian Suppression Agents Market, By Region, 2018-2026 ($Million)
  • Table 05. Others Market, By Region, 2018-2026 ($Million)
  • Table 06. Global Premenstrual Syndrome Treatment Market, By Type, 2018-2026 ($Million)
  • Table 07. Prescription Premenstrual Syndrome Treatment Market, By Region, 2018-2026 ($Million)
  • Table 08. Otc Premenstrual Syndrome Treatment Market, By Region, 2018-2026 ($Million)
  • Table 09. Global Premenstrual Syndrome Treatment Market, By Distribution Channel, 2018-2026 ($Million)
  • Table 10. Premenstrual Syndrome Treatment Market For Hospitals Pharmacies, By Region, 2018-2026 ($Million)
  • Table 11. Premenstrual Syndrome Treatment Market For Drug Stores & Retail Pharmacies, By Region, 2018-2026 ($Million)
  • Table 12. Premenstrual Syndrome Treatment Market For Online Pharmacies, By Region, 2018-2026 ($Million)
  • Table 13. Premenstrual Syndrome Treatment Market Revenue, By Region, 2018-2026 ($Million)
  • Table 14. North America Premenstrual Syndrome Treatment Market, By Country, 2018-2026 ($Million)
  • Table 15. U.S. Premenstrual Syndrome Treatment Market, By Drug Type, 2018-2026
  • Table 16. U.S. Premenstrual Syndrome Treatment Market, By Type, 2018-2026
  • Table 17. U.S. Premenstrual Syndrome Treatment Market, By Distribution Channel, 2018-2026
  • Table 18. Canada Premenstrual Syndrome Treatment Market, By Drug Type, 2018-2026
  • Table 19. Canada Premenstrual Syndrome Treatment Market, By Type, 2018-2026
  • Table 20. Canada Premenstrual Syndrome Treatment Market, By Distribution Channel, 2018-2026
  • Table 21. Mexico Premenstrual Syndrome Treatment Market, By Drug Type, 2018-2026
  • Table 22. Mexico Premenstrual Syndrome Treatment Market, By Type, 2018-2026
  • Table 23. Mexico Premenstrual Syndrome Treatment Market, By Distribution Channel, 2018-2026
  • Table 24. North America Premenstrual Syndrome Treatment Market, By Drug Type, 2018-2026
  • Table 25. North America Premenstrual Syndrome Treatment Market, By Type, 2018-2026
  • Table 26. North America Premenstrual Syndrome Treatment Market, By Distribution Channel, 2018-2026
  • Table 27. Europe Premenstrual Syndrome Treatment Market, By Country, 2018-2026 ($Million)
  • Table 28. Germany Premenstrual Syndrome Treatment Market, By Drug Type, 2018-2026
  • Table 29. Germany Premenstrual Syndrome Treatment Market, By Type, 2018-2026
  • Table 30. Germany Premenstrual Syndrome Treatment Market, By Distribution Channel, 2018-2026
  • Table 31. France Premenstrual Syndrome Treatment Market, By Drug Type, 2018-2026
  • Table 32. France Premenstrual Syndrome Treatment Market, By Type, 2018-2026
  • Table 33. France Premenstrual Syndrome Treatment Market, By Distribution Channel, 2018-2026
  • Table 34. Uk Premenstrual Syndrome Treatment Market, By Drug Type, 2018-2026
  • Table 35. Uk Premenstrual Syndrome Treatment Market, By Type, 2018-2026
  • Table 36. Uk Premenstrual Syndrome Treatment Market, By Distribution Channel, 2018-2026
  • Table 37. Italy Premenstrual Syndrome Treatment Market, By Drug Type, 2018-2026
  • Table 38. Italy Premenstrual Syndrome Treatment Market, By Type, 2018-2026
  • Table 39. Italy Premenstrual Syndrome Treatment Market, By Distribution Channel, 2018-2026
  • Table 40. Spain Premenstrual Syndrome Treatment Market, By Drug Type, 2018-2026
  • Table 41. Spain Premenstrual Syndrome Treatment Market, By Type, 2018-2026
  • Table 42. Spain Premenstrual Syndrome Treatment Market, By Distribution Channel, 2018-2026
  • Table 43. Rest of Europe Premenstrual Syndrome Treatment Market, By Drug Type, 2018-2026
  • Table 44. Rest of Europe Premenstrual Syndrome Treatment Market, By Type, 2018-2026
  • Table 45. Rest of Europe Premenstrual Syndrome Treatment Market, By Distribution Channel, 2018-2026
  • Table 46. Europe Premenstrual Syndrome Treatment Market, By Drug Type, 2018-2026
  • Table 47. Europe Premenstrual Syndrome Treatment Market, By Type, 2018-2026
  • Table 48. Europe Premenstrual Syndrome Treatment Market, By Distribution Channel, 2018-2026
  • Table 49. Asia-Pacific Premenstrual Syndrome Treatment Market, By Country, 2018-2026 ($Million)
  • Table 50. Japan Premenstrual Syndrome Treatment Market, By Drug Type, 2018-2026
  • Table 51. Japan Premenstrual Syndrome Treatment Market, By Type, 2018-2026
  • Table 52. Japan Premenstrual Syndrome Treatment Market, By Distribution Channel, 2018-2026
  • Table 53. China Premenstrual Syndrome Treatment Market, By Drug Type, 2018-2026
  • Table 54. China Premenstrual Syndrome Treatment Market, By Type, 2018-2026
  • Table 55. China Premenstrual Syndrome Treatment Market, By Distribution Channel, 2018-2026
  • Table 56. Australia Premenstrual Syndrome Treatment Market, By Drug Type, 2018-2026
  • Table 57. Australia Premenstrual Syndrome Treatment Market, By Type, 2018-2026
  • Table 58. Australia Premenstrual Syndrome Treatment Market, By Distribution Channel, 2018-2026
  • Table 59. India Premenstrual Syndrome Treatment Market, By Drug Type, 2018-2026
  • Table 60. India Premenstrual Syndrome Treatment Market, By Type, 2018-2026
  • Table 61. India Premenstrual Syndrome Treatment Market, By Distribution Channel, 2018-2026
  • Table 62. South Korea Premenstrual Syndrome Treatment Market, By Drug Type, 2018-2026
  • Table 63. South Korea Premenstrual Syndrome Treatment Market, By Type, 2018-2026
  • Table 64. South Korea Premenstrual Syndrome Treatment Market, By Distribution Channel, 2018-2026
  • Table 65. Rest of Asia-Pacific Premenstrual Syndrome Treatment Market, By Drug Type, 2018-2026
  • Table 66. Rest of Asia-Pacific Premenstrual Syndrome Treatment Market, By Type, 2018-2026
  • Table 67. Rest of Asia-Pacific Premenstrual Syndrome Treatment Market, By Distribution Channel, 2018-2026
  • Table 68. Asia-Pacific Premenstrual Syndrome Treatment Market, By Drug Type, 2018-2026
  • Table 69. Asia-Pacific Premenstrual Syndrome Treatment Market, By Type, 2018-2026
  • Table 70. Asia-Pacific Premenstrual Syndrome Treatment Market, By Distribution Channel, 2018-2026
  • Table 71. Lamea Premenstrual Syndrome Treatment Market, By Country, 2018-2026 ($Million)
  • Table 72. Brazil Premenstrual Syndrome Treatment Market, By Drug Type, 2018-2026
  • Table 73. Brazil Premenstrual Syndrome Treatment Market, By Type, 2018-2026
  • Table 74. Brazil Premenstrual Syndrome Treatment Market, By Distribution Channel, 2018-2026
  • Table 75. Saudi Arabia Premenstrual Syndrome Treatment Market, By Drug Type, 2018-2026
  • Table 76. Saudi Arabia Premenstrual Syndrome Treatment Market, By Type, 2018-2026
  • Table 77. Saudi Arabia Premenstrual Syndrome Treatment Market, By Distribution Channel, 2018-2026
  • Table 78. South Africa Premenstrual Syndrome Treatment Market, By Drug Type, 2018-2026
  • Table 79. South Afria Premenstrual Syndrome Treatment Market, By Type, 2018-2026
  • Table 80. South Africa Premenstrual Syndrome Treatment Market, By Distribution Channel, 2018-2026
  • Table 81. Rest of Lamea Premenstrual Syndrome Treatment Market, By Drug Type, 2018-2026
  • Table 82. Rest of Lamea Premenstrual Syndrome Treatment Market, By Type, 2018-2026
  • Table 83. Rest of Lamea Premenstrual Syndrome Treatment Market, By Distribution Channel, 2018-2026
  • Table 84. Lamea Premenstrual Syndrome Treatment Market, By Drug Type, 2018-2026
  • Table 85. Lamea Premenstrual Syndrome Treatment Market, By Type, 2018-2026
  • Table 86. Lamea Premenstrual Syndrome Treatment Market, By Distribution Channel, 2018-2026
  • Table 87. Abbvie: Company Snapshot
  • Table 88. Abbvie: Operating Business Segments
  • Table 89. Abbvie: Product Portfolio
  • Table 90. Astrazeneca: Company Snapshot
  • Table 91. Astrazeneca: Operating Business Segments
  • Table 92. Astrazeneca: Product Portfolio
  • Table 93. Basf: Company Snapshot
  • Table 94. Basf: Operating Segments
  • Table 95. Basf: Product Portfolio
  • Table 96. Bayer.: Company Snapshot
  • Table 97. Bayer.: Operating Segments
  • Table 98. Bayer.: Product Portfolio
  • Table 99. Dr. Reddy'S: Company Snapshot
  • Table 100. Dr. Reddy'S: Operating Business Segments
  • Table 101. Dr. Reddy'S: Product Portfolio
  • Table 102. Lilly: Company Snapshot
  • Table 103. Lilly: Operating Segments
  • Table 104. Lilly: Product Portfolio
  • Table 105. Gsk: Company Snapshot
  • Table 106. Gsk: Operating Business Segments
  • Table 107. Gsk: Product Portfolio
  • Table 108. Lundbeck: Company Snapshot
  • Table 109. Lundbeck: Operating Business Segments
  • Table 110. Lundbeck: Product Portfolio
  • Table 111. Pfizer: Company Snapshot
  • Table 112. Pfizer: Operating Segments
  • Table 113. Pfizer: Product Portfolio
  • Table 114. Shionogi: Company Snapshot
  • Table 115. Shionogi: Operating Business Segments
  • Table 116. Shionogi: Product Portfolio

List of Figures

  • Figure 01. Top Investment Pockets
  • Figure 02. Top Player Positioning, 2018
  • Figure 03. Global Premenstrual Syndrome Treatment Market Segmentation
  • Figure 04. Impact Analysis
  • Figure 05. Comparative Analysis of Analgesics Market, By Country, 2018 & 2026 ($Million)
  • Figure 06. Comparative Analysis of Antidepressants Market, By Country, 2018 & 2026 ($Million)
  • Figure 07. Comparative Analysis of Oral Contraceptives & Ovarian Suppression Agents Market, By Country, 2018 & 2026 ($Million)
  • Figure 08. Comparative Analysis of Others Market, By Country, 2018 & 2026 ($Million)
  • Figure 09. Comparative Analysis of Prescription Premenstrual Syndrome Treatment Market, By Country, 2018 & 2026 ($Million)
  • Figure 10. Comparative Analysis of Otc Premenstrual Syndrome Treatment Market, By Country, 2018 & 2026 ($Million)
  • Figure 11. Comparative Analysis of Premenstrual Syndrome Treatment Market For Hospitals Pharmacies, By Country, 2018 & 2026 ($Million)
  • Figure 12. Comparative Analysis of Premenstrual Syndrome Treatment Market For Drug Stores & Retail Pharmacies, By Country, 2018 & 2026 ($Million)
  • Figure 13. Comparative Analysis of Premenstrual Syndrome Treatment Market For Online Pharmacies, By Country, 2018 & 2026 ($Million)
  • Figure 14. U.S. Premenstrual Syndrome Treatment Market, 2018-2026 ($Million)
  • Figure 15. Canada Premenstrual Syndrome Treatment Market, 2018-2026 ($Million)
  • Figure 16. Mexico Premenstrual Syndrome Treatment Market, 2018-2026 ($Million)
  • Figure 17. Germany Premenstrual Syndrome Treatment Market, 2018-2026 ($Million)
  • Figure 18. France Premenstrual Syndrome Treatment Market, 2018-2026 ($Million)
  • Figure 19. Uk Premenstrual Syndrome Treatment Market, 2018-2026 ($Million)
  • Figure 20. Italy Premenstrual Syndrome Treatment Market, 2018-2026 ($Million)
  • Figure 21. Spain Premenstrual Syndrome Treatment Market, 2018-2026 ($Million)
  • Figure 22. Rest of Europe Premenstrual Syndrome Treatment Market, 2018-2026 ($Million)
  • Figure 23. Japan Premenstrual Syndrome Treatment Market, 2018-2026 ($Million)
  • Figure 24. China Premenstrual Syndrome Treatment Market, 2018-2026 ($Million)
  • Figure 25. Australia Premenstrual Syndrome Treatment Market, 2018-2026 ($Million)
  • Figure 26. India Premenstrual Syndrome Treatment Market, 2018-2026 ($Million)
  • Figure 27. South Korea Premenstrual Syndrome Treatment Market, 2018-2026 ($Million)
  • Figure 28. Rest of Asia-Pacific Premenstrual Syndrome Treatment Market, 2018-2026 ($Million)
  • Figure 29. Brazil Premenstrual Syndrome Treatment Market, 2018-2026 ($Million)
  • Figure 30. Saudi Arabia Premenstrual Syndrome Treatment Market, 2018-2026 ($Million)
  • Figure 31. South Africa Premenstrual Syndrome Treatment Market, 2018-2026 ($Million)
  • Figure 32. Rest of Lamea Premenstrual Syndrome Treatment Market, 2018-2026 ($Million)
  • Figure 33. Abbvie: Net Sales, 2016-2018 ($Million)
  • Figure 34. Abbvie: Revenue Share By Region, 2018(%)
  • Figure 35. Astrazeneca: Net Sales, 2016-2018 ($Million)
  • Figure 36. Astrazeneca: Revenue Share By Region, 2018(%)
  • Figure 37. Basf: Net Sales, 2016-2018 ($Million)
  • Figure 38. Basf: Revenue Share By Segment, 2018(%)
  • Figure 39. Basf: Revenue Share By Region, 2018(%)
  • Figure 40. Bayer: Net Sales, 2016-2018 ($Million)
  • Figure 41. Bayer.: Revenue Share By Segment, 2018 (%)
  • Figure 42. Bayer.: Revenue Share By Region, 2018(%)
  • Figure 43. Dr. Reddy'S: Net Sales, 2016-2018 ($Million)
  • Figure 44. Dr. Reddy'S: Revenue Share By Segment, 2018 (%)
  • Figure 45. Dr. Reddy'S: Revenue Share By Region, 2018(%)
  • Figure 46. Lilly: Net Sales, 2016-2018 ($Million)
  • Figure 47. Lilly: Revenue Share By Segment, 2018 (%)
  • Figure 48. Lilly: Revenue Share By Region, 2018(%)
  • Figure 49. Gsk: Net Sales, 2016-2018 ($Million)
  • Figure 50. Gsk: Revenue Share By Segment, 2018(%)
  • Figure 51. Gsk: Revenue Share By Region, 2018(%)
  • Figure 52. Lundbeck: Net Sales, 2016-2018 ($Million)
  • Figure 53. Lundbeck: Revenue Share By Segment, 2018 (%)
  • Figure 54. Lundbeck: Revenue Share By Region, 2018(%)
  • Figure 55. Pfizer: Net Sales, 2016-2018 ($Million)
  • Figure 56. Pfizer: Revenue Share By Segment, 2018 (%)
  • Figure 57. Pfizer: Revenue Share By Region, 2018(%)
  • Figure 58. Shionogi: Net Sales, 2016-2018 ($Million)
  • Figure 59. Shionogi: Revenue Share By Region, 2018(%)
  • Figure 60. Sanofi: Revenue Share By Segment, 2018 (%)
  • Figure 61. Sanofi: Revenue Share By Region, 2018(%)